5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Five retirees do a conga line dance on the beach celebrating the special dividend announced by Grange Resources today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One lesson out of last month's reporting season was that cost pressures are persisting for ASX-listed companies.

That's the analysis from Wilsons equity strategist Rob Crookston, who argued that the biggest pressure for businesses at the moment is labour costs.

"For instance, Cleanaway Waste Management Ltd (ASX: CWY) reported a heightened number of job vacancies caused employee costs to rise +16% due to the need to pay more overtime and use more expensive labour hire contractors," he said in a Wilsons memo to clients.

While in the longer term, inflation will settle down, according to Crookston, its effects can't be ignored when deciding which ASX shares to buy at the moment.

"The near-term threat to profitability is… meaningful and we see further downside to margins from here, particularly in more cyclical sectors with less pricing power — e.g. retail, discretionary goods."

So which are the best ASX shares to buy under such conditions?

Nothing beats setting your own prices

According to Crookston, "the best defence against cost inflation is pricing power".

"High quality companies with resilient customer demand through the cycle and dominant market positions operating in attractive industry structures are best placed to protect their margins by raising prices."

He named five such S&P/ASX 200 Index (ASX: XJO) stocks that the Wilsons team holds in its focus portfolio:

Created with Highcharts 11.4.3CSL + ResMed PriceZoom1M3M6MYTD1Y5Y10YALL26 Feb 202424 Feb 2025Zoom ▾Mar '24Apr '24May '24Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25050100150200250300350www.fool.com.au

CSL can set its own prices as the "dominant and lowest-cost player" in the international blood plasma industry, said Crookston.

"The market for immunoglobulin (IG) products is supply constrained, while underlying demand is highly defensive given IG is used to treat patients with a range of serious immunologic and neurologic diseases."

Another medical player, ResMed, already has about 70% of the sleep apnea device market. According to Crookston, it's on its way to supplying the entire market because its nearest rival, Koninklijke Philips NV (AMS: PHIA), is still hamstrung from a 2021 product recall.

Telstra, whose dominance goes without saying for most Australians, is "committed to raising prices annually (and cutting costs) to offset inflation".

"Mobile net ads were strong in 1H23 in spite of higher prices, and the competitive setting is increasingly rational."

Created with Highcharts 11.4.3Telstra Group + Insurance Australia Group + Lottery PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

In the recession-resilient insurance industry, IAG can name its own prices.

"Number 1 general insurer in Australia, which has been [raising] premium rates strongly to offset rising perils costs (albeit there is a timing lag to margins)," said Crookston.

"Even with higher premiums, customer retention rates remain high."

He noted that The Lottery Corporation operates in a monopoly in every state except for Western Australia.

"Lottery sales have historically been [highly] resilient in economic downturns, and TLC has a proven ability to incrementally raise ticket prices over time."

Should you invest $1,000 in CSL right now?

Before you buy CSL shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and CSL wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Tony Yoo has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and ResMed. The Motley Fool Australia has positions in and has recommended ResMed and Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Three guys in shirts and ties give the thumbs down.
Broker Notes

3 reasons to sell Guzman y Gomez shares right now

Goldman Sachs thinks now is the time to sell this fast-food stock.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

These ASX 200 shares could rise 10% to 40%

Analysts are tipping these shares to deliver big returns over the next 12 months.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Down 26%! Buy this ASX 200 stock while it's dirt cheap

Bell Potter thinks this blue chip has been oversold and is in the buy zone now.

Read more »

Rising share price chart.
Broker Notes

Morgans says these top ASX stocks could rise 15% to 20%

The broker thinks these shares could be heading higher from here.

Read more »